Vertex Pharmaceuticals Incorpor
only company marketing FDA-approved drugs, with AI they have potential to find new drugs
2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.
yahoo·yahoo.com·29/09, 10:40
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
yahoo·yahoo.com·29/09, 10:40
2 Healthcare Stocks to Target This Week and 1 We Avoid
Vertex Pharmaceuticals poised for growth with new therapies.
1 source·01/01, 17:01·yahoo.com
Vertex Pharmaceuticals shows promising earnings growth outlook.
1 source·31/12, 05:01·yahoo.com
Leerink raises Vertex price target and maintains Outperform rating.
1 source·30/12, 17:03·yahoo.com
Vertex has strong future growth potential and pipeline.
1 source·30/12, 17:03·yahoo.com
Vertex Pharmaceuticals develops transformative medicines for serious diseases.
1 source·29/12, 23:03·yahoo.com
Vertex stock performance mentioned, no major news.
1 source·29/12, 17:02·yahoo.com
Vertex launches new products, signaling future growth potential.
1 source·28/12, 23:04·yahoo.com
yahoo·yahoo.com·28/09, 10:39
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know
yahoo·yahoo.com·25/09, 00:39
Vertex (VRTX) Stock Could Be 24% Undervalued As Kidney Trial Progress Continues
yahoo·yahoo.com·25/09, 00:39
Twin Moves: VRTX Rises On Kidney Disease Trial Results, MAZE Rallies Harder
yahoo·yahoo.com·23/09, 00:39
Will Vertex’s (VRTX) New CFO Elevation and Digital Focus Reframe Its Capital Allocation Narrative?
yahoo·yahoo.com·16/09, 00:39
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
yahoo·yahoo.com·23/09, 00:39